Authors: GATZEMEIER U JAGOS U KAUKEL E KOSCHEL G VONPAWEL J

Citation: U. Gatzemeier et al., PACLITAXEL, CARBOPLATIN, AND ORAL ETOPOSIDE - A PHASE-II TRIAL IN LIMITED-STAGE SMALL-CELL LUNG-CANCER, Seminars in oncology, 24(4), 1997, pp. 149-152

Authors: DUBOIS A VACH W CRAMERGIRAUD U THOMSSEN C GLAUBITZ M FIOLA M AUGENER W BARTSCH W BERGMANN F BIERBAUM W KRAPP J BONING L BONGARTZ U BRUNTSCH U VONBULTZINGSLOWEN F DIETL J FUGER T FULLE HH GATZEMEIER U GROPP C HARTLAPP H HERSCHLEIN HJ HOLTKAMP W HURST U JANICKE F KAUKEL E KLEEBERG U ENGEL E KRAFFT W KUHNLE H LINDEMANN H MARSCHNER N MEERPOHL HG NIEDERLE N OSIEKA R PLANKER M RIESS H SCHMIDT M SCHMOLL HJ SCHUNEMANN H WEINGARTJESSE B WEITZEL H WESTERHAUSEN M WINKELMANN M

Citation: A. Dubois et al., PATTERN OF CARBOPLATIN-INDUCED EMESIS, Anti-cancer drugs, 6(5), 1995, pp. 645-651

Authors: MEZGER J CALAVREZOS A DRINGS P GATZEMEIER U KAUKEL E KONIETZKO N KOSCHEL G LAMERZ R VONPAWEL J ROMER W

Citation: J. Mezger et al., VALUE OF SERUM AND EFFUSION FLUID CEA LEVELS FOR DISTINGUISHING BETWEEN DIFFUSE MALIGNANT MESOTHELIOMA AND CARCINOMATOUS PLEURAL METASTASES, Lung, 172(3), 1994, pp. 183-184